The Hidden Revenue Leaks Costing Your ASC Six Figures Every Year

You ran a strong quarter. Case volume is up. The OR schedule is full. But when you pull the financial report, the margin doesn’t match the momentum. If that sounds familiar, you’re not alone — and the problem is almost certainly not your case volume. It’s what’s happening between the operating room and the final payment.

Revenue leakage in ambulatory surgery centers is one of the most persistent and underappreciated financial challenges in healthcare. Unlike a denied claim that shows up clearly in your A/R, most leakage happens quietly — in the form of underpayments, missed charge capture, unbilled implants, and coding gaps that compound month after month until the financial damage is significant. At SMP, we’ve seen this pattern across centers of all sizes. The good news: it’s fixable. But only if you know where to look.

The 2026 CMS Rule Just Made This More Complex — and More Urgent

The CY 2026 CMS Final Rule added 560 procedures to the ASC Covered Procedures List and began phasing out the Inpatient-Only list, removing 285 primarily musculoskeletal procedures in the first year alone. This is one of the most significant expansions of ASC procedural eligibility in recent history, and it creates a direct revenue opportunity for centers equipped to capitalize on it.

But here’s the catch: CMS may have updated its coverage policies immediately, while major commercial payers — UnitedHealthcare, Aetna, BCBS — can take 60 to 180 days to update their own internal coverage determinations. That gap is a billing minefield. ASCs that start billing newly eligible cardiology and spine procedures without payer-specific verification in place aren’t just risking denials — they’re funding a systematic revenue loss on the exact cases that were supposed to improve their financial performance.

18–28%  — the average denial rate at ASCs without structured revenue protection protocols, according to industry data. Best-in-class centers operate between 4–6%.

Where the Money Is Actually Going

Implant charge capture gaps. For surgery centers running 200 or more procedures monthly with significant implant utilization, even a modest capture failure rate can eliminate tens of thousands of dollars in billable device revenue per month. The problem isn’t that your staff isn’t trying — it’s that manual processes can’t reliably keep pace with OR volume. Implants get opened, documentation doesn’t reach billing until end-of-month reconciliation, and in some cases it doesn’t reach billing at all. Cancelled procedures where an implant was already opened are among the most chronically unbilled items in an ASC.

Coding drift under new CPT codes. The 2026 update brought new, revised, and deleted CPT codes effective January 1. ICD-10-CM changes followed on October 1, 2025. Charge masters, encoders, and EHR dictionaries that weren’t updated immediately are generating claims with obsolete codes — and payers aren’t calling to tell you. They’re just denying them.

Prior authorization friction. In orthopedics especially, payers have systematically expanded prior authorization requirements over the past three years. This doesn’t just create denials — it creates case delays, administrative burden, and in some centers, cases that get quietly redirected away from the ASC setting entirely. As one ASC leader told Becker’s Healthcare recently: ‘It’s not always about denials. It’s about friction.’

ASCQR non-compliance. Failing to meet ASCQR quality reporting requirements triggers a 2% payment reduction across all applicable services. For a center collecting $1 million to $5 million per month, that’s a six-figure annual hit from a single compliance failure — one that often goes undetected until the payment update arrives.

What Revenue Integrity Actually Looks Like

A clean-claim submission rate matters. But revenue integrity goes further — it’s the operational infrastructure that connects every case performed in your OR to the maximum contracted reimbursement that case is entitled to collect. That means payer-specific verification before scheduling, real-time charge capture during procedures, denial root-cause analysis (not just appeal), and regular contract reviews to identify systematic underpayments.

ASC leaders increasingly report that they have strong visibility into gross collections and case volume, but limited consistency in identifying where performance leakage exists. That visibility gap is itself a revenue risk. You can’t fix what you can’t measure.

At SMP, revenue cycle review is one of the first things we assess when working with a new center — because the data rarely lies. Most centers we engage with have recoverable revenue hiding in plain sight. The question is whether leadership has the systems and bandwidth to find it.

$1.2M–$3.8M  — estimated annual revenue recovery potential for ASCs with unresolved charge capture, denial, and payer-variance gaps, according to 2026 industry benchmarks.

Three Questions Every ASC Administrator Should Be Asking Right Now

•     What is our current net collection ratio by procedure category — and how does it benchmark against our payer contracts?
•     Have we verified that all 560 new CPL procedures are cleared with commercial payer coverage policies before billing?
•     When did we last conduct a systematic implant charge capture audit against our OR logs?

If any of those questions produce uncertainty, you likely have recoverable revenue sitting in your billing workflow right now.